Europe Parenteral Nutrition Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)

No. of Pages: 90    |    Report Code: BMIRE00030424    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Parenteral Nutrition Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Parenteral Nutrition Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Parenteral Nutrition Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.
5.2 Market Opportunities
  • 5.2.1 New product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.
5.3 Future Trends
  • 5.3.1 Innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.
5.4 Impact of Drivers and Restraints

6. Europe Parenteral Nutrition Market Regional Analysis

6.1 Europe Parenteral Nutrition Market Overview
6.2 Europe Parenteral Nutrition Market Revenue 2020-2030 (US$ Million)
6.3 Europe Parenteral Nutrition Market Forecast Analysis

7. Europe Parenteral Nutrition Market Analysis – by Nutrient Type

7.1 Single Dose Amino Acid Solution
  • 7.1.1 Overview
  • 7.1.2 Single Dose Amino Acid Solution: Europe Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Parenteral Lipid Emulsion
  • 7.2.1 Overview
  • 7.2.2 Parenteral Lipid Emulsion: Europe Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Carbohydrates
  • 7.3.1 Overview
  • 7.3.2 Carbohydrates: Europe Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Trace Elements
  • 7.4.1 Overview
  • 7.4.2 Trace Elements: Europe Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Vitamins and Minerals
  • 7.5.1 Overview
  • 7.5.2 Vitamins and Minerals: Europe Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Parenteral Nutrition Market Analysis – by End User

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Clinics
  • 8.2.1 Overview
  • 8.2.2 Clinics: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Parenteral Nutrition Market – Europe Analysis

9.1 Europe
  • 9.1.1 Europe Parenteral Nutrition Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 9.1.1.1 Europe Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.1.1 UK: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.1.2 UK: Europe Parenteral Nutrition Market Breakdown, by End User
  • 9.1.1.2 Germany: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.2.1 Germany: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.2.2 Germany: Europe Parenteral Nutrition Market Breakdown, by End User
  • 9.1.1.3 France: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.3.1 France: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.3.2 France: Europe Parenteral Nutrition Market Breakdown, by End User
  • 9.1.1.4 Russia: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.4.1 Russia: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.4.2 Russia: Europe Parenteral Nutrition Market Breakdown, by End User
  • 9.1.1.5 Italy: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.5.1 Italy: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.5.2 Italy: Europe Parenteral Nutrition Market Breakdown, by End User
  • 9.1.1.6 Rest of Europe: Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.6.1 Rest of Europe: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
    • 9.1.1.6.2 Rest of Europe: Europe Parenteral Nutrition Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Europe Parenteral Nutrition Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 ICU Medical Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Grifols SA
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Pfizer Inc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Otsuka Pharmaceuticals Co Ltd
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Baxter International Inc
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 B Braun SE
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Fresenius Kabi AG
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Aculife Healthcare Pvt Ltd
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Vifor Pharma Management AG
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - E Market

1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd 
9. Vifor Pharma Management AG